{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:04:41Z","timestamp":1715940281699},"reference-count":35,"publisher":"Europa Digital & Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.4244\/eijv8i10a184","type":"journal-article","created":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T07:59:44Z","timestamp":1374479984000},"page":"1199-1206","source":"Crossref","is-referenced-by-count":10,"title":["Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients"],"prefix":"10.4244","volume":"8","author":[{"given":"Matthijs A.","family":"Velders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hel\u00e8n","family":"Boden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas L.","family":"van der Hoeven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-San","family":"Liem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja\u00ebl Z.","family":"Atary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst E.","family":"van der Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Schalij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-201363020310-0","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ccd.22428","article-title":"Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.","volume":"75","author":"Wiemer M.","year":"2010","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-201363020310-1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/ccd.22770","article-title":"Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial.","volume":"77","author":"Garg S.","year":"2011","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-201363020310-2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.amjcard.2010.10.069","article-title":"Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial).","volume":"107","author":"Applegate RJ.","year":"2011","journal-title":"Am J Cardiol."},{"key":"key-201363020310-3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jacc.2011.02.022","article-title":"Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial.","volume":"58","author":"Stone GW.","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201363020310-4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jacc.2011.02.023","article-title":"2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERT\u00c9 stent in all-comers: a randomized open label trial).","volume":"58","author":"Smits PC.","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201363020310-5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ccd.22206","article-title":"Five-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study.","volume":"74","author":"Meredith IT.","year":"2009","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-201363020310-6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4244\/EIJV6I5A95","article-title":"Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study.","volume":"6","author":"Fajadet J.","year":"2010","journal-title":"EuroIntervention."},{"key":"key-201363020310-7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jcin.2010.12.014","article-title":"Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).","volume":"4","author":"Kandzari DE.","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201363020310-8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jcin.2010.07.008","article-title":"Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.","volume":"3","author":"Leon MB.","year":"2010","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201363020310-9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jacc.2009.03.013","article-title":"Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.","volume":"53","author":"Brar SS.","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"key-201363020310-10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0002-8703(07)00008-7","article-title":"MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction.","volume":"153","author":"Liem SS.","year":"2007","journal-title":"Am Heart J."},{"key":"key-201363020310-11","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-201363020310-12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/eurheartj\/ehs036","article-title":"Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction.","volume":"33","author":"Kalesan B.","year":"2012","journal-title":"Eur Heart J."},{"key":"key-201363020310-13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","article-title":"Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.","volume":"172","author":"De Luca G.","year":"2012","journal-title":"Arch Intern Med."},{"key":"key-201363020310-14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCINTERVENTIONS.108.844985","article-title":"Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.","volume":"2","author":"Lagerqvist B.","year":"2009","journal-title":"Circ Cardiovasc Interv."},{"key":"key-201363020310-15","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.amjcard.2010.01.347","article-title":"Angiographic predictors of recurrent stent thrombosis (from the Outcome of PCI for stent-ThrombosIs MultIcentre STudy [OPTIMIST]).","volume":"105","author":"Porto I.","year":"2010","journal-title":"Am J Cardiol."},{"key":"key-201363020310-16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jacc.2007.04.059","article-title":"Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.","volume":"50","author":"Sianos G.","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"key-201363020310-17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.4244\/EIJV7I9A164","article-title":"Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomized trial.","volume":"7","author":"Boden H.","year":"2012","journal-title":"EuroIntervention."},{"key":"key-201363020310-18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents.","volume":"52","author":"Joner M.","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-201363020310-19","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.105.591206","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.","volume":"114","author":"Fajadet J.","year":"2006","journal-title":"Circulation."},{"key":"key-201363020310-20","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.","volume":"299","author":"Stone GW.","year":"2008","journal-title":"JAMA."},{"key":"key-201363020310-21","article-title":"Everolimus-eluting stents and zotarolimus-eluting stents for percutaneous coronary interventions: Two-year outcomes in New York state.","volume":"Epub AOP","author":"Hannan EL.","year":"2012 Jun 18.","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-201363020310-22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","article-title":"Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.","volume":"380","author":"Sabate M.","year":"2012","journal-title":"Lancet."},{"key":"key-201363020310-23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2012.01.073","article-title":"Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.","volume":"60","author":"Hofma SH.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-201363020310-24","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.4244\/EIJV7I12A217","article-title":"Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial.","volume":"7","author":"Kedhi E.","year":"2012","journal-title":"EuroIntervention."},{"key":"key-201363020310-25","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.","volume":"377","author":"Stone GW.","year":"2011","journal-title":"Lancet."},{"key":"key-201363020310-26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.amjcard.2009.11.009","article-title":"Comparison of outcomes between Zotarolimus- and sirolimus-eluting stents in patients with ST-segment elevation acute myocardial infarction.","volume":"105","author":"Kim HK.","year":"2010","journal-title":"Am J Cardiol."},{"key":"key-201363020310-27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4244\/EIJV7I8A148","article-title":"Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial.","volume":"7","author":"Kang WC.","year":"2011","journal-title":"EuroIntervention."},{"key":"key-201363020310-28","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1253\/circj.CJ-11-0263","article-title":"Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome.","volume":"75","author":"Lee MG.","year":"2011","journal-title":"Circ J."},{"key":"key-201363020310-29","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.amjcard.2009.06.059","article-title":"Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.","volume":"104","author":"Lee CW.","year":"2009","journal-title":"Am J Cardiol."},{"key":"key-201363020310-30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1540-8183.2011.00674.x","article-title":"Three-year clinical outcome with the Endeavor\u2122 zotarolimus-eluting stent in primary percutaneous coronary intervention for ST elevation myocardial infarction: the Endeavor\u2122 primary PCI study (E-PPCI).","volume":"24","author":"Shelton RJ.","year":"2011","journal-title":"J Interv Cardiol."},{"key":"key-201363020310-31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(11)60395-4","article-title":"Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.","volume":"377","author":"Silber S.","year":"2011","journal-title":"Lancet."},{"key":"key-201363020310-32","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A randomized controlled trial in second-generation zotarolimus-eluting resolute stents versus everolimus-eluting XIENCE V stents in real-world patients: the TWENTE trial.","volume":"59","author":"von Birgelen C.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-201363020310-33","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1111\/j.1538-7836.2010.04046.x","article-title":"Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome.","volume":"8","author":"Heestermans AA.","year":"2010","journal-title":"J Thromb Haemost."},{"key":"key-201363020310-34","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2011.1529","article-title":"Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis.","volume":"306","author":"Cayla G.","year":"2011","journal-title":"JAMA."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T04:27:19Z","timestamp":1715747239000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/57th_issue\/184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["EIJV8I10A184"],"URL":"https:\/\/doi.org\/10.4244\/eijv8i10a184","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}